| Document Date: 2010-11-09 09:19:41
Open Document File Size: 90,12 KBShare Result on Facebook
City Nantes / / Company IN CELL ART / CELL ART / CELL-ART IN CELL ART / / Country France / / / Event Labor Issues / FDA Phase / / / IndustryTerm preclinical and pharmaceutical development / biotechnology / multivalent immunization protocol / biotechnology development services / biopharmaceutical company specialising / therapeutic products / high-tech cluster / / MedicalCondition cancers / tumor / cardiovascular and antiinfectious diseases / infectious diseases / / MedicalTreatment immunization / / Person Bruno Pitard / Alexis Ricordeau / Chloé Bellocq / Merial / Benoît Barteau / / / Position CEO / leader / scientific adviser and co-founder / / Product ICANtibodies® / / Region western France / / Technology antibodies / siRNA / biotechnology / multivalent immunization protocol / stem cells / / URL www.incellart.com / /
SocialTag |
In Cell Art and Merial enter into a research collaboration agreement Nantes – France, 9 November, 2010 – IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA, DNA) delivery systems, has announc